Medical Devices
Supporting development, validation, translation and adoption of indigenous medical devices.
About MI-PPP
A dedicated unit for advancing biomedical innovation, technology translation and public–private collaboration
Overview
Advancing Biomedical Innovation Ecosystem
The ICMR–Medical Innovations Public-Private Partnership (MI-PPP) Unit serves as a dedicated unit within ICMR to administer, coordinate and facilitate national biomedical innovation initiatives through a whole-of-government and public–private partnership approach.
The Unit brings together innovation-focused programmes and stakeholder partnerships to strengthen the complete biomedical innovation pathway — from idea, intellectual property and product development to validation, technology transfer, commercialization and adoption.
The MI-PPP Unit oversees and facilitates flagship initiatives including Medical Innovations Patent Mitra, MedTech Mitra, and other innovator- and industry-facing initiatives aimed at accelerating biomedical innovation and translating research into meaningful public health impact.
Established at
ICMR Headquarters, New Delhi
Approach
Whole-of-government & public–private partnership
Flagship initiatives
Patent Mitra · MedTech Mitra
28
Institutes in the network
37+
Technologies available for licensing
300
Patent filings supported
41
Technologies transferred
Our Vision
“To nurture and protect India’s biomedical innovation ecosystem by transforming research into intellectual property, indigenous healthcare technologies and impactful health solutions for advancing public health.”
Protecting Ideas Enabling Innovation Connecting Industry Accelerating Impact
Key Mandates
Key functions of the MI-PPP Unit.
-
01
Nurturing and protecting India’s biomedical innovation ecosystem
Strengthening India’s biomedical intellectual property ecosystem by facilitating the identification, protection and strategic utilization of intellectual property, and accelerating the translation and commercialization of innovations developed by ICMR intramural and extramural grantees, medical colleges, research institutions, start-ups, MSMEs and other biomedical innovators through the flagship Medical Innovations Patent Mitra initiative.
-
02
Technology transfer & innovator–industry engagement
Facilitating technology transfer, industry partnerships, and implementation of technology transfer and biomaterial transfer mechanisms for commercialization of healthcare technologies through Medical Innovations Patent Mitra.
-
03
Biomedical innovation facilitation through ICMR–CDSCO MedTech Mitra
Accelerating translation of biomedical research into affordable, accessible and globally competitive healthcare technologies through strategic innovation facilitation, technology maturation and industry engagement — from technology development, regulatory facilitation and clinical validation to market adoption.
-
04
Biomedical entrepreneurship & technology translation ecosystem development
Fostering entrepreneurship development, strategic partnerships and coordinated implementation of technology translation initiatives through nationwide implementation of policies such as the ICMR/DHR Policy on Biomedical Innovation & Entrepreneurship for Medical Professionals, Scientists and Technologists at Medical, Dental and Para-Medical Institutes/Colleges.
-
05
Other innovator- and industry-facing initiatives
Any other innovator and / or industry facing initiatives to advance the biomedical innovation ecosystem.
Our Focus Areas
Priority domains where MI-PPP supports biomedical innovation, translation and health impact.
In-Vitro Diagnostics
Enabling promising diagnostic technologies to progress towards validation, regulatory readiness and deployment.
Therapeutics
Supporting translation of innovative therapeutic technologies towards real-world healthcare applications.
Vaccines
Facilitating pathways for promising vaccine innovations towards development, validation and wider use.
Digital Health Technologies
Encouraging technology-enabled solutions that address emerging healthcare needs.
Assistive Technologies
Promoting innovative solutions that improve accessibility, independence and quality of life.
Biomaterial Transfers
Facilitating secure and strategic transfer of biomaterials and related research resources to accelerate translation.
Emerging Technologies
Supporting frontier biomedical technologies with enabling pathways for validation, translation and commercialization.
Have an innovation ready for the next step?
Whether you want to protect, validate, develop, transfer or commercialize a biomedical innovation, the MI-PPP ecosystem can help you find the right pathway.